Cargando…
Identification of Protein Expression Changes in Hepatocellular Carcinoma through iTRAQ
BACKGROUND: Hepatocellular carcinoma (HCC) is a malignant tumor associated with a poor prognosis. Serum biomarkers of HCC have the potential to improve the diagnosis, provide a means to monitor the tumors, and predict their malignancy. Proteins that are expressed differentially between HCC patients...
Autores principales: | Zhang, Yuanyuan, Ying, Xia, Zhao, Qian, Ma, Jinlu, Zhang, Dan, He, Chenchen, Han, Suxia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7008262/ https://www.ncbi.nlm.nih.gov/pubmed/32076459 http://dx.doi.org/10.1155/2020/2632716 |
Ejemplares similares
-
Identification of CD14 as a potential biomarker of hepatocellular carcinoma using iTRAQ quantitative proteomics
por: Guo, Jiao, et al.
Publicado: (2017) -
Identification of Candidate Biomarkers in Malignant Ascites from Patients with Hepatocellular Carcinoma by iTRAQ-Based Quantitative Proteomic Analysis
por: Zhang, Jinyan, et al.
Publicado: (2018) -
Identification of novel biomarkers for neonatal hypoxic-ischemic encephalopathy using iTRAQ
por: Zhu, Yuanyuan, et al.
Publicado: (2020) -
Identification of chemoresistant factors by protein expression analysis with iTRAQ for head and neck carcinoma
por: Nishimura, K, et al.
Publicado: (2014) -
i-Tracker: For quantitative proteomics using iTRAQ™
por: Shadforth, Ian P, et al.
Publicado: (2005)